Results 21 to 30 of about 5,469,873 (362)
ESC Heart Failure, 2023 The amount of evidence for guideline‐directed new heart failure (HFrEF) disease‐modifying drugs in the context of chronic kidney disease (CKD) is relatively modest, especially in end‐stage CKD. We report a case of dramatic reverse remodelling and disease
Massimo Mapelli +7 more
doaj +1 more source
ESC Heart Failure, 2020 Aims Acute myocardial infarction (MI) is the major cause of chronic heart failure. The activity of blood coagulation factor XIII (FXIIIa) plays an important role in rodents as a healing factor after MI, whereas its role in healing and remodelling ...
Anna Frey +12 more
doaj +1 more source
ESC Heart Failure, 2023 Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare multisystem disorder; cardiac involvement may include eosinophilic myocarditis. A 67‐year‐old woman presented with 1‐week history of dyspnoea and orthopnoea.
Nicola Amelotti +12 more
doaj +1 more source
International Journal of Hypertension, 2022 Background. Most of the patients with hypertension (HTN) who undergo medical therapy unaccompanied by psychological and behavioral interventions may not achieve their goal in HTN treatment. Self-care is a key factor in controlling HTN.
Maryam Eghbali +11 more
doaj +1 more source
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
New England Journal of Medicine, 2014 BACKGROUND We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction. In previous studies, enalapril improved survival in such patients.
J. McMurray +10 more
semanticscholar +1 more source
Prevalence, incidence and survival of heart failure: a systematic review
Heart, 2022 Studies of the epidemiology of heart failure in the general population can inform assessments of disease burden, research, public health policy and health system care delivery.
Sophia Emmons-Bell +2 more
semanticscholar +1 more source
Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018
Scientific Reports, 2021 To assess mortality trends at 1 and 3 years from 2001 to 2018 in a real-life cohort of HF outpatients from different etiologies with depressed and preserved LVEF.
Giosafat Spitaleri +15 more
doaj +1 more source
Cardiac Energy Metabolism in Heart Failure
Circulation Research, 2021 Alterations in cardiac energy metabolism contribute to the severity of heart failure. However, the energy metabolic changes that occur in heart failure are complex and are dependent not only on the severity and type of heart failure present but also on ...
G. Lopaschuk +4 more
semanticscholar +1 more source
The role of the gut microbiome in sex differences in arterial pressure
Biology of Sex Differences, 2019 There has been intense interest in the role of the gut microbiome in human health and a broad range of diseases in recent years. In the context of cardiovascular disease, gut dysbiosis (defined as a change in the gut microbiome and the gut-epithelial ...
Anna L. Beale +2 more
doaj +1 more source
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
New England Journal of Medicine, 2020 BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure or death from cardiovascular causes among patients with stable heart failure.
Deepak L. Bhatt +18 more
semanticscholar +1 more source